336 related articles for article (PubMed ID: 14576480)
1. Use of oxytocin receptor expression in distinguishing between uterine smooth muscle tumors and endometrial stromal sarcoma.
Loddenkemper C; Mechsner S; Foss HD; Dallenbach FE; Anagnostopoulos I; Ebert AD; Stein H
Am J Surg Pathol; 2003 Nov; 27(11):1458-62. PubMed ID: 14576480
[TBL] [Abstract][Full Text] [Related]
2. Use of myocardin in the classification of mesenchymal tumors of the uterus.
Liang J; Wu L; Xiao H; Li N; Wang H; Cheng C; Bai R; Zhao Y; Zheng H
Int J Gynecol Pathol; 2010 Jan; 29(1):55-62. PubMed ID: 19952936
[TBL] [Abstract][Full Text] [Related]
3. h-Caldesmon, a novel smooth muscle-specific antibody, distinguishes between cellular leiomyoma and endometrial stromal sarcoma.
Rush DS; Tan J; Baergen RN; Soslow RA
Am J Surg Pathol; 2001 Feb; 25(2):253-8. PubMed ID: 11176075
[TBL] [Abstract][Full Text] [Related]
4. h-Caldesmon expression effectively distinguishes endometrial stromal tumors from uterine smooth muscle tumors.
Nucci MR; O'Connell JT; Huettner PC; Cviko A; Sun D; Quade BJ
Am J Surg Pathol; 2001 Apr; 25(4):455-63. PubMed ID: 11257619
[TBL] [Abstract][Full Text] [Related]
5. An immunohistochemical analysis of endometrial stromal and smooth muscle tumors of the uterus: a study of 54 cases emphasizing the importance of using a panel because of overlap in immunoreactivity for individual antibodies.
Oliva E; Young RH; Amin MB; Clement PB
Am J Surg Pathol; 2002 Apr; 26(4):403-12. PubMed ID: 11914617
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical markers in differential diagnosis of endometrial stromal sarcoma and cellular leiomyoma.
Zhu XQ; Shi YF; Cheng XD; Zhao CL; Wu YZ
Gynecol Oncol; 2004 Jan; 92(1):71-9. PubMed ID: 14751141
[TBL] [Abstract][Full Text] [Related]
7. Utility of CD10 in distinguishing between endometrial stromal sarcoma and uterine smooth muscle tumors: an immunohistochemical comparison of 34 cases.
Chu PG; Arber DA; Weiss LM; Chang KL
Mod Pathol; 2001 May; 14(5):465-71. PubMed ID: 11353058
[TBL] [Abstract][Full Text] [Related]
8. Use of histone deacetylase 8 (HDAC8), a new marker of smooth muscle differentiation, in the classification of mesenchymal tumors of the uterus.
de Leval L; Waltregny D; Boniver J; Young RH; Castronovo V; Oliva E
Am J Surg Pathol; 2006 Mar; 30(3):319-27. PubMed ID: 16538051
[TBL] [Abstract][Full Text] [Related]
9. CD10 imunostaining does not distinguish endometrial carcinoma invading myometrium from carcinoma involving adenomyosis.
Srodon M; Klein WM; Kurman RJ
Am J Surg Pathol; 2003 Jun; 27(6):786-9. PubMed ID: 12766582
[TBL] [Abstract][Full Text] [Related]
10. Epithelioid endometrial and endometrioid stromal tumors: a report of four cases emphasizing their distinction from epithelioid smooth muscle tumors and other oxyphilic uterine and extrauterine tumors.
Oliva E; Clement PB; Young RH
Int J Gynecol Pathol; 2002 Jan; 21(1):48-55. PubMed ID: 11781523
[TBL] [Abstract][Full Text] [Related]
11. Endometrial stromal neoplasms are immunoreactive with WT-1 antibody.
Sumathi VP; Al-Hussaini M; Connolly LE; Fullerton L; McCluggage WG
Int J Gynecol Pathol; 2004 Jul; 23(3):241-7. PubMed ID: 15213600
[TBL] [Abstract][Full Text] [Related]
12. Expression of subtype-specific group 1 leiomyosarcoma markers in a wide variety of sarcomas by gene expression analysis and immunohistochemistry.
Mills AM; Beck AH; Montgomery KD; Zhu SX; Espinosa I; Lee CH; Subramanian S; Fletcher CD; van de Rijn M; West RB
Am J Surg Pathol; 2011 Apr; 35(4):583-9. PubMed ID: 21412072
[TBL] [Abstract][Full Text] [Related]
13. Transgelin, a Novel Marker of Smooth Muscle Differentiation, Effectively Distinguishes Endometrial Stromal Tumors from Uterine Smooth Muscle Tumors.
Tawfik O; Rao D; Nothnick WB; Graham A; Mau B; Fan F
Int J Gynecol Obstet Reprod Med Res; 2014 Sep; 1(1):26-31. PubMed ID: 26023684
[TBL] [Abstract][Full Text] [Related]
14. [Immunohistochemical study of endometrial stromal sarcoma and smooth-muscle tumors of the uterus].
Farah-Klibi F; Ben Hamouda S; Ben Romdhane S; Sfar R; Koubaa A; Ben Jilani S; Zermani R
J Gynecol Obstet Biol Reprod (Paris); 2008 Sep; 37(5):457-62. PubMed ID: 18565690
[TBL] [Abstract][Full Text] [Related]
15. Endometrial stromal sarcomas with unusual histologic features: a report of 24 primary and metastatic tumors emphasizing fibroblastic and smooth muscle differentiation.
Yilmaz A; Rush DS; Soslow RA
Am J Surg Pathol; 2002 Sep; 26(9):1142-50. PubMed ID: 12218570
[TBL] [Abstract][Full Text] [Related]
16. IFITM1 Outperforms CD10 in Differentiating Low-grade Endometrial Stromal Sarcomas From Smooth Muscle Neoplasms of the Uterus.
Busca A; Gulavita P; Parra-Herran C; Islam S
Int J Gynecol Pathol; 2018 Jul; 37(4):372-378. PubMed ID: 28700435
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical panel to differentiate endometrial stromal sarcoma, uterine leiomyosarcoma and leiomyoma: something old and something new.
Hwang H; Matsuo K; Duncan K; Pakzamir E; Pham HQ; Correa A; Fedenko A; Mhawech-Fauceglia P
J Clin Pathol; 2015 Sep; 68(9):710-7. PubMed ID: 25991737
[TBL] [Abstract][Full Text] [Related]
18. [Highly cellular leiomyoma of uterus: a comparative morphologic and immunohistochemical study of endometrial stromal tumors].
Liao X; Wang Y; Yue C; Liu Y; Wang H; Dai L; Hui Y
Zhonghua Bing Li Xue Za Zhi; 2002 Oct; 31(5):396-400. PubMed ID: 12485478
[TBL] [Abstract][Full Text] [Related]
19. CD10 is a sensitive and diagnostically useful immunohistochemical marker of normal endometrial stroma and of endometrial stromal neoplasms.
McCluggage WG; Sumathi VP; Maxwell P
Histopathology; 2001 Sep; 39(3):273-8. PubMed ID: 11532038
[TBL] [Abstract][Full Text] [Related]
20. [Myxoid mesenchymal tumors of uterus: endometrial stromal and smooth muscle tumors, myxoid variant].
Chesnais AL; Watkin E; Beurton D; Devouassoux-Shisheboran M
Ann Pathol; 2011 Jun; 31(3):152-8. PubMed ID: 21736994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
